CELLINK and Kugelmeiers partner to bring to market CELLINK Spheroid Kits

CELLINK is partnering with Kugelmeiers Ltd. to bring to market CELLINK Spheroid Kits, which package Kugelmeiers Sphericalplate 5D for forming highly standardized spheroids with CELLINK’s vast portfolio of bioinks. The Spheroid Kits will be distributed globally, except in Japan and Switzerland, through CELLINK’s existing marketing and distribution network.
“We are happy to partner with Kugelmeiers on this distribution agreement for the cutting-edge Sphericalplate 5D, which complements our existing portfolio of 3D cell culturing technologies and expanding library of high-quality bioinks. CELLINK strongly believes 3D cell culturing is the future of medicine and is committed to researching, developing and distributing to the scientific community the tools vital to making that change a reality,” said Magnus Lindeberg, Bioprinting Product Manager, CELLINK.
Culturing cell spheroids is an important emerging field for cell biologists that can be used in scientific, diagnostic and therapeutic applications. When coupled with 3D bioprinting, the enhanced biological functionality and accuracy of spheroids can be used like “building blocks” for tissue engineering. Kugelmeiers’ Sphericalplate 5D allows for the formation of up to 9,000 spheroids per plate, enabling the high–throughput development of spheroids in a reproducible and cell–friendly manner. The partnership makes CELLINK Spheroid Kits available to help researchers optimize workflows for an automated solution to spheroid development.
“In Kugelmeiers vision to enable unlimited cell therapies, it is a great honour for us to partner with CELLINK – the leading provider for 3D bioprinting technologies. We strongly believe that the combination of the high quality bioinks from CELLINK and our 3D cell culture technology Sphericalplate 5D will help to find functional and empowering solutions for the global scientific, diagnostic and medical community,” added Manfred Vogel, Director of Sales, Kugelmeiers.
CELLINK recognizes the paradigm shift toward 3D cellular models in medical research and is committed to providing scientists with better access to the necessary tools and supplies. As demonstrated in the literature, 3D models better mimic in vivo conditions, and CELLINK researchers have found that pairing CELLINK’s bioinks with Kugelmeiers’ Sphericalplate 5D results in improved cellular rearrangement and yields more physiologically relevant data about cellular behavior. A recent CELLINK white paper outlines the benefits of spheroids within the realm of 3D cell culture.